CTA
ICUI icon

Carillon Tower Advisers’s ICU Medical ICUI Stock Holding History

Carillon Tower Advisers’s Portfolio ICUI Stock Details ICUI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$5.65M Sell
26,338
-900
-3% -$175K 0.03% 401
2020
Q3 		$4.98M Sell
27,238
-805
-3% -$152K 0.07% 334
2020
Q2 		$5.17M Sell
28,043
-742
-3% -$147K 0.04% 366
2020
Q1 		$5.81M Sell
28,785
-2,600
-8% -$500K 0.06% 329
2019
Q4 		$5.87M Sell
31,385
-900
-3% -$155K 0.04% 383
2019
Q3 		$5.15M Sell
32,285
-200
-0.6% -$39.8K 0.04% 386
2019
Q2 		$8.18M Buy
32,485
+625
+2% +$145K 0.06% 353
2019
Q1 		$7.63M Sell
31,860
-63
-0.2% -$15.1K 0.05% 355
2018
Q4 		$7.33M Sell
31,923
-2,600
-8% -$641K 0.06% 330
2018
Q3 		$9.76M Sell
34,523
-12
-0% -$3.52K 0.07% 340
2018
Q2 		$10.1M Sell
34,535
-2,482
-7% -$678K 0.08% 323
2018
Q1 		$9.34M Buy
37,017
+34,927
+1,671% +$8.21M 0.07% 312
2017
Q4 		$451K Buy
+2,090
New +$423K ﹤0.01% 291

Other funds holding ICUI

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NI
Nuance Investments Kansas City, Missouri $588M AUM 6.93% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
FPP
Findlay Park Partners London, United Kingdom $7.41B AUM 26.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NC
Nitorum Capital New York $147M AUM 45.08% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Carillon Tower Advisers's ICUI Position: Q4 2020 in Review

Carillon Tower Advisers reduced its ICU Medical (ICUI) stake by 3.3% in Q4 2020, selling an estimated $175K and leaving 26,338 shares worth $5.65M. The position accounts for 0.03% of the portfolio, ranked #401.

Carillon Tower Advisers first reported a position in ICUI in Q4 2017 and has held it in 13 quarters since. The position peaked at $10.1M in Q2 2018. 284 funds tracked by Wall St. Rank hold ICUI as of Q4 2020.

  • Carillon Tower Advisers held 26,338 shares of ICU Medical worth $5.65M as of Q4 2020.
  • Carillon Tower Advisers sold 900 ICU Medical shares in Q4 2020, an estimated $175K.
  • ICU Medical made up 0.03% of Carillon Tower Advisers's portfolio in Q4 2020, its #401 holding.
  • Carillon Tower Advisers first reported a position in ICU Medical in Q4 2017 and has held it in 13 quarters since.
  • Carillon Tower Advisers's ICU Medical position peaked at $10.1M in Q2 2018.
  • 284 funds tracked by Wall St. Rank held ICU Medical as of Q4 2020.

Based on Carillon Tower Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.